RANDOMIZED CLINICAL TRIALS AND REVIEW OF EVERYDAY CLINICAL PRACTICE: WHAT IT MEANS FOR THE CLINICIAN. LECTURE
.
Saved in:
| Main Author: | I. S. Yavelov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«REMEDIUM GROUP» Ltd.
2018-05-01
|
| Series: | Атеротромбоз |
| Online Access: | https://www.aterotromboz.ru/jour/article/view/149 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN EVERYDAY CLINICAL PRACTICE: FACTS ABOUT RIVAROXABAN
by: I. S. Yavelov
Published: (2016-07-01) -
Rivaroxaban in stroke prevention in patients with non-valvular atrial fibrillation: what facts are important for the clinician?
by: I. S. Yavelov
Published: (2025-08-01) -
What can a tandem of a pathophysiologist and a clinician bring to clinical practice?
by: A.I. Gozhenko, et al.
Published: (2024-06-01) -
The implications of randomized, controlled clinical trials in glaucoma on clinical practice: What does the evidence tell us?
by: Patricia M. Khu, MD, MS, et al.
Published: (2004-06-01) -
2025 GOLD Report: What is New and What is Noteworthy for the Practicing Clinician
by: Konstantinos Kostikas, et al.
Published: (2025-01-01)